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In this report, we demonstrate a direct correlation between protein kinase C (PKC) activity and adriamycin (ADR) resist- 
ance in mouse fibrosarcoma cells. PKC activity was measured in four murine UV-2237M fibrosarcoma cell lines that 
differed in the degrees to which they expressed resistance toADR, which is an inhibitor of PKC. A comparison ofthe 
four cell lines revealed a positive correlation between the level of PKC activity and resistance to ADR. Incubation of 
the cells with the PKC inhibitor H-7 produced a partial reversal of ADR resistance. Taken together, these results uggest 
a role for PKC in the mechanism of ADR resistance. 
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1. INTRODUCTION 
Protein kinase C, a Ca 2+- and phospholipid- 
dependent protein kinase, is implicated in the 
regulation of cell growth, since it plays a critical 
role in the signal transduct ion mechanisms of cer- 
tain growth factors and other mitogens, and 
because it is specifically activated by phorbol ester 
tumor  promoters [1,2]. Adr iamycin (ADR) is an 
antineoplastic drug that appears to exert its bio- 
logical effects through multiple biochemical 
mechanisms. ADR intercalates DNA, perturbs cell 
membranes and inhibits calmodulin. In addition, 
ADR is a PKC inhibitor [3]. ADR can be used to 
select cells with a mult idrug resistance phenotype 
[4,5]. MDR cells are resistant to a broad range of 
structurally unrelated anticancer drugs [6,7]. MDR 
has been associated with a net decrease in the in- 
tracellular accumulat ion of drugs and with overex- 
pression of a membrane-associated p170 glycopro- 
tein [6,7]. It was recently reported that an MDR 
human breast cancer cell line expressed elevated 
levels of PKC activity [8]. In this report, we 
demonstrate a direct correlation between ADR 
resistance and PKC activity in four murine fibro- 
sarcoma cell lines which differ in their sensitivities 
to ADR.  We also report a partial reversal of  ADR 
resistance in these cells with the PKC inhibitor H-7. 
2. MATERIALS  AND METHODS 
Correspondence address': C.A. O'Brian, Department of Cell 
Biology (HMB 173), U.T.M.D. Anderson Cancer Center, 1515 
Holcombe Boulevard, Houston, TX 77030, USA 
Abbreviations: CMEM, Eagle's minimal essential medium sup- 
plemented with 10°70 fetal bovine serum, sodium pyruvate, 
nonessential mino acids, vitamins and L-glutamine; DEAE, 
diethylaminoethyl; H-7, 1-(5-isoquinolinesulfonyl)-2-methyl- 
piperazine dihydrochloride; MDR, multidrug resistant; PDBu, 
phorbol dibutyrate; PMSF, phenylmethylsulfonyl fluoride; 
PKC, protein kinase C; PS, phosphatidylserine 
2. I. Tumor cell lines 
The parental UV-2237 fibrosarcoma was induced in a 
C3H/Hen (mammary tumor negative) mouse by chronic ex- 
posure to ultraviolet-B radiation [9]; the UV-2237M line was 
isolated from spontaneous lung metastases of the parental line 
[10]. Both lines are sensitive to the cytotoxic effects of ADR. 
UV-2237M-ADR cells and UV-2237M-ADR R cells were 
selected from the UV-2237M cells by their capacities to pro- 
liferate in the presence of 1 /zg/ml [4] and 10/~g/ml ADR, 
respectively. UV-2237M-rev cells were derived from UV-2237M- 
ADR R cells subsequent to growth for 4 months in the absence of
ADR [11]; they exhibited an intermediate level of resistance to
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ADR. UV-2237M-ADR R and UV-2237M-ADR RR were main- 
tained in the continual presence of 1/~g/ml and 10,ug/ml ADR, 
respectively. 
2.2. Reagents 
[y)zP]ATP was purchased from Amersham Corp. (Arlington 
Heights, IL). Protein concentrations were determined with the 
BioRad protein assay solution (BioRad, Richmond, CA). ADR 
was purchased from Adria (Columbus, OH). All other reagents 
were from Sigma (St. Louis, MO). 
without H-7. After 48 h, cell proliferation was determined by a 
modification of  a colorimetric tetrazolium procedure [13]. 
Briefly, at the end of  the assay period, 50/A of tetrazolium dye 
at 5 mg/ml  in phosphate-buffered saline was added to each well, 
and cells were incubated for 2 h at 37°C. After reaction of the 
dye with mitochondrial dehydrogenase in the viable cells, the 
dye and media were removed, dimethyl sulfoxide was added to 
each well, and the absorbance at 590 nm was measured with a 
microplate scanning spectrophotometer. 
2.3. Isolation of  PKC activity from UV-2237M, UV-2237M- 
rev, UV-2237M-ADR  and UV-2237M-ADR R cells 
Cell lines were maintained on plastic in 10% CMEM, and the 
media for the maintenance of the UV-2237M-ADR g and the 
UV-2237M-ADR RR cell lines contained 1/zg/ml and 10/zg/ml 
ADR, respectively. ADR was removed from the medium of the 
cells 24 h before they were harvested for the isolation of PKC. 
Subconfluent cells (approx. 3 × 106) were harvested with buf- 
fer A containing 0.1% Triton X-100 (20 mM Tris-HCl, 5 mM 
EDTA, 5 mM EGTA, 15 mM 2-mercaptoethanol, 10/zg/ml 
leupeptin, 0.25 mM PMSF, 25,ug/ml soybean trypsin inhibitor, 
0.I % Triton X-100, pH 7.5). All subsequent procedures were 
done at 4°C. Cell suspensions were stirred for 1 h and then cen- 
trifuged at 13 800 × g for 15 rain. Supernatants were loaded on- 
to 0.5-ml DEAE-Sephacel columns equilibrated in buffer A. 
The columns were washed with 3 ml buffer A, and PKC was 
then eluted with 2 ml of  0.2 M NaC1 in buffer A. 
In experiments designed to determine PKC activities in 
cytosolic and particulate cell fractions, the procedure described 
above was followed with the following modifications. Cells were 
scraped into buffer A without Triton X-100. The cells were 
manually homogenized with a glass homogenizer (50 strokes) 
and then spun at 100000 x g for 1 h. The supernatant con- 
tained the cytosolic fraction. The pellet was resuspended in buf- 
fer A containing 0.1% Triton X-100 (5 ml), stirred for 2 h, and 
then centrifuged for 15 min at 13 800 × g. The supernatant 
represented the particulate fraction. Cytosolic and particulate 
fractions were chromatographed on DEAE-Sephacel. 
2.4. Assay of  PKC activity 
Levels of PKC activity were determined using the DEAE- 
purified cell extracts. PKC activity was measured as previously 
described [12], by subtracting the pbosphotransferase activity 
between [7-3zPIATP and histone III-S observed in the presence 
of  I mM Ca 2÷ from the activity observed in the presence of 1 
mM Ca ~÷ plus 30,ug PS/ml.  
2.5. Assay for  in vitro growth inhibition by ADR and effects 
o f  H-7 
Cultures of  the UV-2237M cell lines in their exponential 
growth phase were harvested by a brief exposure to 0.25% tryp- 
sin/0.02% EDTA (w/v). Single-cell suspensions with a viability 
of >95% (trypan blue exclusion) were seeded into 96-well 
microculture plates at 2 500 cells/well and incubated for 24 h at 
37°C in a humidified atmosphere containing 5% CO2. For PKC 
inhibitor (H-7) studies, the cells were incubated with various 
concentrations (1-100,uM) of H-7 (or HA1004) for 60 rain prior 
to the addition of 5 /~g/ml ADR. Control cultures were in- 
cubated in medium with or without H-7 but without ADR. Ad- 
ditional controls consisted of  cells incubated with ADR, but 
3. RESULTS 
3.1. Cytostatic effects of ADR 
We first examined the sensitivities of the four 
UV-2237M cell lines to cytostatic effects of ADR. 
The data of fig.1 show that parental UV-2237M 
cells were highly sensitive to the cytostatic effects 
of ADR. In contrast, resistance to ADR was 
greatest in UV-2237M-ADR RR and UV-2237M- 
ADR R cells, and intermediate in UV-2237M-rev 
cells. 
3.2. Levels of PKC activity in UV-2237M, 
UV-2237M-rev, UV-2237M-ADR  and 
UV-2237M-ADR R cell lines 
Next we determined whether a correlation ex- 
isted between levels of PKC activity and the ADR 
resistance phenotype of cell lines derived from 
UV-2237M cells. Table 1 shows that cells highly 
resistant to ADR (UV-2237M-ADR • and UV- 
2237M-ADR RR) had twice as much PKC activity as 
ADR-sensitive cells (UV-2237M). In addition, cells 
with intermediate resistance (UV-2237M-rev) had 
elevated levels of PKC activity relative to the drug- 
sensitive cells (UV-2237M) but less PKC activity 
than that found in the highly resistant cell lines 
(UV-2237M-ADR R and UV-2237M-ADRRR). The 
data indicate that acquisition of the resistance 
phenotype correlates with elevated PKC activity 
and that partial loss of the resistance phenotype 
observed in UV-2237M-ADR R cells that were 
grown in the absence of ADR for 4 months 
(UV2237M-rev) correlates with reduced PKC ac- 
tivity. 
3.3. Reversal of the ADR resistance phenotype in
UV-2237M-rev and UV-2237M-ADR ~ cells 
by the PKC inhibitor H-7 
H-7, an isoquinolesulfonamide, is an active-site 
inhibitor of PKC [14]. In order to assess the 
significance of elevated PKC activity in the ADR 
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Fig.1. Cytostatic effects of ADR on various UV-2237M cell lines. Effects of the indicated concentrations of ADR on UV-2237M, 
UV-2237M-rev, UV-2237M-ADR R and UV-2237M-ADR RR cells were determined. Each bar represents he average (+_ SD) of  triplicate 
determinations. 
resistance phenotypes of UV-2237M-rev and 
UV-2237M-ADR R cells, we tested the capacity of 
H-7 to reverse the resistance phenotype. H-7, at the 
concentrations shown in fig.2, did not produce 
cytostasis. However, H-7 increased the sensitivity 
of UV-2237M-rev and UV-2237M-ADR R cells to 
ADR (fig.2). HA1004, a structural analogue of 
H-7 and a weak PKC inhibitor [14], failed to in- 
crease the ADR sensitivity of either UV-2237M-rev 
or UV-2237M-ADR R cells at concentrations from 
10 to 100/~M (not shown). H-7 was more potent in 
reversing the resistance phenotype of the UV- 
2237M-rev cells that that of the UV-2237M-ADR R 
cells. These data indicate that the levels of PKC ac- 
tivity in UV-2237M-rev and UV-2237M-ADR R 
ceils correlate inversely with the capacity of H-7 to 
reverse resistance to ADR. 
4. DISCUSSION 
In this study, we examined whether expression of 
Table 1 
Levels of PKC activity in rnurine fibrosarcoma cell lines exhibiting different sensitivities to 
adriamycin 
Cell line Total Background PKC % 
activity activity activity particulate 
UV-2237M 1069 +_ 50 445 _+ 50 624 73 +_ 16 
UV-2237M-rev 1449 + 73 498 ___ 61 951 65 +_ 17 
UV-2237M-ADR R 1670 +_ 90 173 +_ 13 1497 50 +_ 8 
UV-2237M-ADR Rg 1218 _+ 69 68 + 24 1150 - 
'PKC activity' represents he pmol 3~p transferred to histone II I-S/min per mg cellular extract 
protein in a Ca 2+- and PS-dependent, PKC-catalyzed phosphotransferase reaction between 
[7-3/P]ATP and histone III-S. 'Total activity' represents he total phosphotransferase ctivity 
between histone IlI-S and [-r-32p]ATP observed in the presence of Ca 2+ and PS; and 
'background activity' represents he phosphotransferase ctivity observed in the presence of 
Ca 2+. PKC activity was calculated as the difference between total and background 
phosphotransferase ctivities. '% particulate' represents the percentage of the total PKC ac- 
tivity that was observed in the particulate fraction of the indicated cell line 
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Fig.2. The effects of the PKC inhibitor H-7 on the ADR resistance phenotype. Each bar represents he average ( _+ SD) of duplicate or 
triplicate determinations. Cells were incubated in the presence of 5/zg/ml of ADR with various concentrations of H-7. The effects of 
adriamycin and H-7 on cell growth were expressed as the percentage ofcontrol and analyzed by the formula (B/A) x 100, where A is 
the A590 observed with the control cells and B is the A590 associated with the treated cells. 
ADR resistance was associated with elevated levels 
of  PKC activity. Indeed, we observed that the 
highly resistant cell lines UV-2237M-ADR R and 
UV-2237M-ADR RR contained twice as much PKC 
activity as the parental  ADR-sensit ive UV-2237M 
cells, and that the part ia l  reversal of  the resistance 
phenotype by the removal  of  ADR for four months 
f rom the culture medium of  the UV-2237M-ADR R 
cells was accompanied by a signif icant reduct ion in 
PKC activity. The level of  PKC activity in the in- 
termediate ly resistant cells was signif icantly greater 
than that observed in the drug-sensit ive UV- 
2237M-parental  cells. Whi le the decreased level of  
PKC activity found in the UV-2237M-rev cells may 
reflect the selection of  a subpopulat ion of  relatively 
drug-sensit ive cells, the data clearly demonstrate a 
posit ive correlat ion between the degree of  
resistance of  ADR and the level of  PKC activity in 
UV-2237M f ibrosarcoma cells. 
H-7 is a PKC inhibitor that acts at the active site 
of  the enzyme, and HA1004 is a structural  analog 
o f  H-7 that inhibits PKC only very weakly. We 
found that H-7, but not HA l004,  could part ia l ly 
reverse the drug resistance phenotype of  UV- 
2237M-ADR R and UV-2237M-rev cells. The ex- 
tents to which H-7 reversed ADR resistance in these 
cell lines correlated inversely with their level of  
PKC activity. Our observat ions that ADR-res istant  
cells have elevated levels of  PKC activity and that a 
selective PKC inhibitor can part ial ly reverse ADR 
resistance in these cells provide evidence that 
maintenance of  ADR resistance is associated with 
expression of  PKC.  
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